American Conference Institute's Conference on Professional Responsibility and Legal Ethics for Life Sciences Attorneys
23-25 February 2015
A stellar array of attorneys representing pharmaceutical, biotech, diagnostic, and medical device companies unite to discuss relevant ethical standards and delve into the particular challenges and complexities facing counsel in the life sciences space including:
- Avoiding ethical landmines in the discovery process and interpreting document production requests post-Actos
- Understanding the role of counsel and balancing the mandate of zealous advocacy against other duties
- Protecting privilege across jurisdictions for global life sciences companies
- Avoiding conflicts of interest in the increasingly interrelated life sciences world
- Civility in litigation: lessons for Hatch-Waxman, white collar, and products liability lawyers from Judges and top counsel
Ms. Waltz’s presentation will address understanding the standard for a common interest where privilege may kick in, including:
- Making it clear that you are giving or seeking legal advice in the digital world of emails and texts
- Business advice versus privileged attorney communications
- Keeping confidential information private in an age when oversharing is commonplace
- Case studies: Vioxx litigation and non-privileged email communications
- Providing information in the discovery context without breaching attorney-client privilege
- Creating a privilege log
- Good document practices and confidentiality agreements
- Setting up your systems so that confidentiality is protected
- Knowing when to exercise the clawback provision
- Conducting witness interviews during litigation with privilege to the client in mind
- Protecting privilege across jurisdictions and across borders: choice of law and applicable rules both internationally and within different states
- Putting protective orders in place and avoiding inadvertent waivers with privileged info during discovery
- Rule 502(d) orders
- Samsung v. Apple
- Understanding the situations where an attorney either is permitted to or has a duty to make a disclosure which defeats privilege
- Sarbanes Oxley mandates
- SEC disclosures
- Crime fraud exception
The conference will be held February 24-25, 2015 at the Union League in Philadelphia, PA. To get more information and to register, please visit the American Conference Institute’s website.
People
Related Insights
July 17, 2025
Health Care Law Today
One Big Beautiful Bill: Slashed Budgets Will Disrupt the Medicaid Program
The new federal budget law, the One Big Beautiful Bill Act (the Act), enacted on July 4, 2025, makes dramatic changes to the Medicaid…
July 16, 2025
Foley Viewpoints
Changes to the College and University Endowment Tax
The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…
July 16, 2025
Health Care Law Today Podcast
Episode 36: Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance
In this episode, Monica Chmielewski, vice chair of Foley’s Health Care Practice Group and Shannon Sumner, Chief Compliance Officer and Nashville’s Office Managing Principal of PYA explore how supply chain compliance is affecting the health care industry and share the risks and penalties associated with not being in compliance.